What are the major opportunities in the Neurodiagnostics market? What are the strategies for the Neurodiagnostics market?

For detailed insights on the major opportunities and strategies in the Neurodiagnostics market, Read More

How does the Neurodiagnostics market relate to the overall economy and other similar markets?

For detailed insights on Neurodiagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neurodiagnostics market growth? SWOT analysis of the Neurodiagnostics market.

For detailed insights on the key dynamics influencing the Neurodiagnostics market growth and SWOT analysis of the Neurodiagnostics industry, Read More

Global Neurodiagnostics Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Neurodiagnostics Global Market Report 2025

Name: Neurodiagnostics Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Diagnostic And Imaging Solutions, In-Vitro Diagnostics), By Technology (Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics), By Condition (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions), By End Use (Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neurodiagnostics Market Overview

• Neurodiagnostics market size has reached to $9.17 billion in 2024

• Expected to grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%

• Growth Driver: Rising Prevalence Of Neurological Disorders Driving Growth In The Market

• Market Trend: Advancements In AI-Driven Software For Enhanced Diagnostic Accuracy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurodiagnostics Market?

Neurodiagnostics refers to the medical field focused on diagnosing and monitoring disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. It involves the use of advanced technologies and tests to assess neurological function, identify abnormalities, and aid in the diagnosis of conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.?

The main types of neurodiagnostic are diagnostic and imaging solutions and In-Vitro Diagnostics. Diagnostic and imaging solutions involve medical technologies and services designed to diagnose health conditions using various imaging techniques and diagnostic tools. Key technologies include neuroimaging, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging (PET, SPECT), near-infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG), voxel-based morphometry (VBM), and neuroinformatics. These diagnostic tools are essential in the treatment of conditions such as epilepsy, alzheimer's disease, parkinson's disease, stroke, joint health issues, and others and are utilized in hospitals, clinics, diagnostic laboratories, imaging centers, and others.

Neurodiagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Neurodiagnostics Market Size 2025 And Growth Rate?

What Is The Neurodiagnostics Market Growth Forecast?

The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. neurological care by increasing costs for quantitative Electroencephalography(EEG) headsets and evoked potential testing equipment sourced from Sweden and China, potentially compromising seizure disorder diagnosis and raising neurophysiology lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Neurodiagnostics Market Segmented?

1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics

2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics

3) By Condition: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions

4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses

Subsegments:

1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors

2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders

What Is Driving The Neurodiagnostics Market? Rising Prevalence Of Neurological Disorders Driving Growth In The Market

The increasing prevalence of neurological disorders is expected to drive the growth of the neurodiagnostics market going forward. Neurological disorders are conditions that impact the brain, spinal cord, or nerves, leading to various cognitive, motor, and sensory impairments. The rise in neurological disorders is largely due to aging populations, environmental factors, lifestyle changes, genetics, and better diagnostic techniques. Neurodiagnostics are essential for accurately identifying, assessing, and monitoring neurological disorders, enabling precise diagnosis, informed treatment decisions, and effective management of conditions affecting the brain, spinal cord, and nerves. For instance, in April 2023, according to the National Library of Medicine, a US-based medical library for medical research information, it was reported that, in 2023, 6.7 million Americans are affected by Alzheimer's, and this number is expected to grow to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the neurodiagnostics industry.

Who Are The Major Players In The Global Neurodiagnostics Market?

Major companies operating in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.

What Are The Key Trends Of The Global Neurodiagnostics Market? Advancements In AI-Driven Software For Enhanced Diagnostic Accuracy

Major companies operating in the neurodiagnostics market are focusing on technological advancements such as an advanced software algorithm to enhance diagnostic accuracy and improve patient outcomes. An advanced software algorithm refers to a sophisticated set of instructions that processes and analyzes data using techniques such as artificial intelligence (AI) or machine learning to enhance decision-making and diagnostics. For instance, in October 2023, Ceribell Inc., a US-based medical equipment manufacturing company, launched the ClarityPro AI algorithm, marking a significant advancement in diagnosing electrographic status epilepticus (ESE). This state-of-the-art software, integrated into the Ceribell EEG system, leverages machine learning to analyze EEG waveforms and deliver real-time alerts for suspected seizures. Notably, ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis. This innovative technology is designed to improve clinical decision-making by continuously monitoring brain activity, offering actionable insights, and enabling faster and more effective treatment responses.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neurodiagnostics Market? ArchiMed SAS Acquires Natus Medical To Expand Healthcare Innovation

In July 2022, ArchiMed SAS, a France-based investment company focused on healthcare industries, acquired Natus Medical Incorporated for $1.1 billion. The acquisition strengthens ArchiMed's position in neurodiagnostic devices and leverages Natus' expertise to drive innovation and growth. Natus Medical Incorporated is a US-based medical device company that specializes in medical devices for screening, diagnosing, and treating neurological disorders.

What Is The Regional Outlook For The Global Neurodiagnostics Market?

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurodiagnostics Market?

The neurodiagnostics market includes revenues earned by entities by providing services such as electroencephalography (EEG), positron emission tomography (PET), cerebrospinal fluid (CSF) analysis, and sleep apnea diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodiagnostic market consists of sales of transcranial magnetic stimulation (TMS) devices, magnetoencephalography (MEG) systems, polysomnography (PSG) devices, and biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neurodiagnostics Industry?

The neurodiagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurodiagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neurodiagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.79 billion
Revenue Forecast In 2034	$12.68 billion
Growth Rate	CAGR of 6.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The neurodiagnostics market covered in this report is segmented – 1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics 2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics 3) By Condition: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions 4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses Subsegments: 1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors 2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neurodiagnostics Market Characteristics

3. Neurodiagnostics Market Trends And Strategies

4. Neurodiagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurodiagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Neurodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Neurodiagnostics Market Growth Rate Analysis

5.4. Global Neurodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Neurodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Neurodiagnostics Total Addressable Market (TAM)

6. Neurodiagnostics Market Segmentation

6.1. Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic And Imaging Solutions

In-Vitro Diagnostics

6.2. Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neuroimaging Technologies

Computed Tomography (CT)

Magnetic Resonance Imaging (MRI)

Nuclear Medicine Imaging (PET, SPECT)

Near Infrared Spectroscopic Imaging (NIRS)

Electro-Encephalography (EEG)

Magneto-Encephalography (MEG)

Voxel Based Morphometry (VBM)

Neuroinformatics

6.3. Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Epilepsy

Alzheimer's Disease

Parkinson's Disease

Stroke

Joint Health

Other Conditions

6.4. Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Laboratories

Imaging Centers

Other End Uses

6.5. Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

MRI (Magnetic Resonance Imaging) Systems

CT (Computed Tomography) Scanners

EEG (Electroencephalogram) Systems

EMG (Electromyography) Systems

MEG (Magnetoencephalography) Systems

PET (Positron Emission Tomography) Scanners

SPECT (Single Photon Emission Computed Tomography) Scanners

Functional MRI (fMRI) Systems

Intracranial Pressure Monitors

6.6. Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood-Based Diagnostics

Cerebrospinal Fluid (Csf) Analysis

Genetic Testing And Biomarkers

Neurochemical Diagnostics

Point-Of-Care Neurodiagnostics

Diagnostic Kits For Neurodegenerative Disorders

7. Neurodiagnostics Market Regional And Country Analysis

7.1. Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurodiagnostics Market

8.1. Asia-Pacific Neurodiagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurodiagnostics Market

9.1. China Neurodiagnostics Market Overview

9.2. China Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurodiagnostics Market

10.1. India Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurodiagnostics Market

11.1. Japan Neurodiagnostics Market Overview

11.2. Japan Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurodiagnostics Market

12.1. Australia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurodiagnostics Market

13.1. Indonesia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurodiagnostics Market

14.1. South Korea Neurodiagnostics Market Overview

14.2. South Korea Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurodiagnostics Market

15.1. Western Europe Neurodiagnostics Market Overview

15.2. Western Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurodiagnostics Market

16.1. UK Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurodiagnostics Market

17.1. Germany Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurodiagnostics Market

18.1. France Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurodiagnostics Market

19.1. Italy Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurodiagnostics Market

20.1. Spain Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurodiagnostics Market

21.1. Eastern Europe Neurodiagnostics Market Overview

21.2. Eastern Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurodiagnostics Market

22.1. Russia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurodiagnostics Market

23.1. North America Neurodiagnostics Market Overview

23.2. North America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurodiagnostics Market

24.1. USA Neurodiagnostics Market Overview

24.2. USA Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurodiagnostics Market

25.1. Canada Neurodiagnostics Market Overview

25.2. Canada Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurodiagnostics Market

26.1. South America Neurodiagnostics Market Overview

26.2. South America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurodiagnostics Market

27.1. Brazil Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurodiagnostics Market

28.1. Middle East Neurodiagnostics Market Overview

28.2. Middle East Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurodiagnostics Market

29.1. Africa Neurodiagnostics Market Overview

29.2. Africa Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurodiagnostics Market Competitive Landscape And Company Profiles

30.1. Neurodiagnostics Market Competitive Landscape

30.2. Neurodiagnostics Market Company Profiles

30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

31. Neurodiagnostics Market Other Major And Innovative Companies

31.1. Ceribell Inc.

31.2. CND Life Sciences Inc.

31.3. Lifelines Neuro Inc.

31.4. ANT Neuro B.V.

31.5. Neurovative Diagnostics LLC

31.6. Firefly Neuroscience Inc

31.7. IntraNerve Neuroscience Inc

31.8. NeuroDiagnostics Laboratories LLC

31.9. Advanced Brain Monitoring Inc

31.10. Spes Medica S.r.l.

31.11. BioSignal Group Inc

31.12. Combinostics Inc.

31.13. Deymed Diagnostic LLC

31.14. NeuLine Health Inc.

31.15. Ridge Diagnostics Inc.

32. Global Neurodiagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurodiagnostics Market

34. Recent Developments In The Neurodiagnostics Market

35. Neurodiagnostics Market High Potential Countries, Segments and Strategies

35.1 Neurodiagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Neurodiagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Neurodiagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Nihon Kohden Corporation Financial Performance

Table 78: Cephalon LLC Financial Performance

Table 79: Stratus Neuro LLC Financial Performance

Table 80: Cadwell Industries Inc. Financial Performance

Table 81: Compumedics Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Nihon Kohden Corporation Financial Performance

Figure 78: Cephalon LLC Financial Performance

Figure 79: Stratus Neuro LLC Financial Performance

Figure 80: Cadwell Industries Inc. Financial Performance

Figure 81: Compumedics Limited Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Nephrologists Global Market Report 2020 - By Practice (Owner- Solo Practice, Owner- Group Practice, Full-time Employed, Partner), By Density (Higher Density Of Nephrologists, Median Density Of Nephrologists, Lower Densit...

Clinical Diagnostics Global Market Report 2025 – By Test (Lab Test, Imaging Test, Other Tests), By Product (Instruments, Reagents, Other Products), By End User (Hospital Laboratory, Diagnostic Laboratory, Point-Of-Care T...

Neurological Biomarkers Global Market Report 2025 – By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products), By Application (Alzheimer’s Disease, Parkinson’s Disea...

Autism Spectrum Disorder Diagnostics Global Market Report 2025 – By Type (Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder (PDD), Other Types), By Service (Behavioral Approaches, Early Intervention, M...

Neurology Devices Global Market Report 2025 – By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devi...

Brain Monitoring Global Market Report 2025 – By Product (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial Pressure Monitoring Devices, Other Pro...

Neurology Monitoring Global Market Report 2025 – By Product Type (Magnetic Resonance Imaging (MRI) Devices, Electroencephalography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, Other Product Types), By Dis...

Frequently Asked Questions

What is the definition of the Neurodiagnostics market?

How will the Neurodiagnostics market drivers and restraints affect the market dynamics? What forces will shape the Neurodiagnostics industry going forward?

The market major growth driver - Rising Prevalence Of Neurological Disorders Driving Growth In The Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Neurodiagnostics market?

The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rise in prevalence of neurological disorders, increase in adoption of advanced imaging technologies, growth in geriatric population, increase in awareness of early disease diagnosis, expanding healthcare infrastructure, and rise in investments in neuroscience research and development. The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to " $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans. For further insights on this market, request a sample here

How is the Neurodiagnostics market segmented?

The neurodiagnosticsmarket covered in this report is segmented –
1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics
2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics
3) By Condition: Epilepsy; Alzheimer's Disease; Parkinson's Disease; Stroke; Joint Health; Other Conditions
4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses Subsegments:
1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors
2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders For further insights on this market, request a sample here

Which region has the largest share of the Neurodiagnostics market? What are the other regions covered in the report?

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Neurodiagnostics market?

What are the key trends in the Neurodiagnostics market?

Major trends in this market include Advancements In AI-Driven Software For Enhanced Diagnostic Accuracy. For further insights on this market, request a sample here.